Continuous Manufacturing Centers Of Excellence Measure Resurfaces In US House
Stand-alone bill headed for Senate, where it fared poorly in coronavirus response legislative packages.
You may also be interested in...
US legislation could advance new manufacturing platforms for drugs and biologics with academic R&D and workforce development and in turn spur domestic growth.
House tries again to promote advanced technology for the return of pharmaceutical manufacturing to the US in post-COVID-19 era.
The association for manufacturers of generics and biologics calls for public sector investment in priority medicines.